Robert Coffin - 16 May 2022 Form 4 Insider Report for Replimune Group, Inc. (REPL)

Role: President & Chief R&D Officer, Director
Signature: /s/ Jean Franchi, attorney-in-fact
Issuer symbol: REPL
Transactions as of: 16 May 2022
Net transactions value: -$83,703
Form type: 4
Filing time: 18 May 2022, 19:01:19 UTC
Previous filing: 05 Apr 2022
Next filing: 04 Apr 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	REPL	Common Stock	Sale	$83,703	-5,737	-0.32%	$14.59	1,796,197	16 May 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of the Issuer's common stock sold to cover tax withholding obligations in connection with the partial vesting of the Reporting Person's Restricted Stock Units ("RSU"). The transaction reported herein was made in accordance with the irrevocable "sell to cover" provision set forth in the award agreement under which the RSU was granted and does not represent a discretionary sale by the Reporting Person.

Content

Represents shares of the Issuer's common stock sold to cover tax withholding obligations in connection with the partial vesting of the Reporting Person's Restricted Stock Units ("RSU"). The transaction reported herein was made in accordance with the irrevocable "sell to cover" provision set forth in the award agreement under which the RSU was granted and does not represent a discretionary sale by the Reporting Person.